About the Connective Tissue Disease - Interstitial Lung Disease (CTD-ILD) Working Group

Interstitial lung diseases (ILD), including those related to connective tissue disease (CTD), and idiopathic pulmonary fibrosis (IPF) carry high morbidity and mortality.

Great efforts are under way to develop and investigate meaningful treatments in the context of clinical trials. However, efforts have been challenged by a lack of validated outcome measures and by inconsistent use of measures in clinical trials.

Khanna Headshot

Dinesh Khanna

Co-Chair

Montesi_Picture

Sydney Montesi

Co-Chair

 

susanna proudman

Susanna Proudman

Co-Chair

Simon Walsh

Co-Chair

Athol Wells

Co-Chair

david roofeh

David Roofeh

Fellow

Jesudasen, Sirus Jonathan

Sirus Jesudasen

Fellow

Technical Advisory Group Instrument Townhall Presentation from the CTD-ILD group of their Instruments for Lung Physiology

OMERACT Endorsed Core Domain Set Clinical Trials in Connective Tissue Disease - Interstitial Lung Disease (CTD-ILD)

ctd ild core set

Working Group Members:

Prof. Dinesh Khanna
Prof. Joanna Porter
Puja Mehta
David Roofeh
Jeff Swirgis
Toby Maher
Fernando Martinez
Chris Denton
Kevin Brown

Scroll to Top